Representing Variability and Transmural Differences in a Model of Human Heart Failure

IEEE Journal of Biomedical and Health Informatics

Volumn 19, Issue 4, 2015, Pages 1308-1320

  Elshrif, Mohamed M ^a   Shi, Pengcheng ^a   Cherry, Elizabeth M ^b  

^a Rochester Institute of Technology   (United States)

^b ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alternans (ALTs); early afterdepolarizations (EADs); heart failure (HF); O'Hara Vir g Varr Rudy (OVVR); remodeling ionic currents

Indexed keywords

CARDIOLOGY; CYTOLOGY; ELECTROPHYSIOLOGY;

ALTERNANS (ALTS); EARLY AFTER DEPOLARIZATION; ELECTROPHYSIOLOGICAL PROPERTIES; HEART FAILURE; IONIC CURRENT; MODELING AND SIMULATING; VENTRICULAR ARRHYTHMIAS; VENTRICULAR CELLS;

CELLS;

ACTION POTENTIAL; BIOLOGICAL MODEL; HEART; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; HEART; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC;

EID: 84938374209     PISSN: 21682194     EISSN: 21682208     Source Type: Journal    
DOI: 10.1109/JBHI.2015.2442833     Document Type: Article

References (96)

1. A. S. Go et al., "Heart disease and stroke statistics - 2014 update: A report from the American Heart Association," Circulation, vol. 128, pp. 00-00, 2013.
2. R. Coronel et al., "Electrophysiological changes in heart failure and their implications for arrhythmogenesis," Biochimica et Biophysica Acta (BBA), Molecular Basis Disease, vol. 1832, no. 12, pp. 2432-2441, 2013.
3. A. V. Glukhov, "Transmural dispersion of repolarization in failing and nonfailing human ventricle," Circulation Res., vol. 106, no. 5, pp. 981-991, 2010.
4. Q. Lou et al., "Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure," Circulation, vol. 123, no. 17, pp. 1881-1890, 2011.
5. M. Luo and M. E. Anderson, "Mechanisms of altered ca2+ handling in heart failure," Circulation Res., vol. 113, no. 6, pp. 690-708, 2013.
6. S. Nattel, et al., "Arrhythmogenic ion-channel remodeling in the heart: Heart failure, myocardial infarction, and atrial fibrillation," Physiol. Rev., vol. 87, no. 2, pp. 425-456, 2007.
7. M. J. Cutler et al., "Cardiac electrical remodeling in health and disease," Trends Pharmacological Sci., vol. 32, no. 3, pp. 174-180, 2011.
8. L. Priebe and D. J. Beuckelmann, "Simulation study of cellular electric properties in heart failure," Circulation Res., vol. 82, no. 11, pp. 1206-1223, 1998.
9. Y. Zhang et al., "Simulation study of transmural cellular electrical properties in failed human heart," in Proc. 27th Annu. Int. Conf. Eng. Med. Biol. Soc., Jan. 2005, pp. 337-340.
10. B. Trenor et al., "Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human heart failure," PLoS ONE, vol. 7, no. 3, p. e32659, Mar. 2012.
11. R. L. Winslow et al., "Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, ii: Model studies," Circulation Res., vol. 84, no. 5, pp. 571-586, 1999.
12. Y. Zang and L. Xia, " Electrical remolding and mechanical changes in heart failure: A model study," in Life System Modeling and Intelligent Computing (ser. Lecture Notes in Computer Science), vol. 6330, K. E. A. Li, Ed. Berlin, Germany: Springer, 2010, pp. 421-429.
13. R. L. Winslow et al., "Modeling the cellular basis of altered excitationcontraction coupling in heart failure," Prog. Biophys. Molecular Biol., vol. 69, nos. 2/3, pp. 497-514, 1998.
14. S. Zlochiver, "Subthreshold parameters of cardiac tissue in a bi-layer computer model of heart failure," Cardiovasc. Eng., vol. 10, no. 4, pp. 190-200, 2010.
15. T. O'Hara et al., "Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation," PLoS Comput. Biol., vol. 7, no. 5, p. e1002061, May 2011.
16. J. Walmsley et al., "mRNA expression levels in failing human hearts predict cellular electrophysiological remodeling: A population-based simulation study," PLoS ONE, vol. 8, no. 2, p. e56359, Feb. 2013.
17. T. R. Shannon et al., "Regulation of cardiac sarcoplasmic reticulum Ca release by luminal [Ca] and altered gating assessed with a mathematical model," Biophys. J., vol. 89, no. 6, pp. 4096-4110, 2005.
18. J. L. Puglisi and D. M. Bers, "LabHEART: An interactive computer model of rabbit ventricular myocyte ion channels and Ca transport," Am. J. Physiol., Cell Physiol., vol. 281, no. 6, pp. C2049-C2060, 2001.
19. S. M. Narayan et al., "Action potential dynamics explain arrhythmic vulnerability in human heart failure: A clinical and modeling study implicating abnormal calcium handling," J. Am. College Cardiol., vol. 52, no. 22, pp. 1782-1792, 2008.
20. J. D. Moreno et al., "A computational model to predict the effects of class i anti-arrhythmic drugs on ventricular rhythms," Sci. Translational Med., vol. 3, no. 98, p. 98ra83, 2011.
21. L. Lu et al., "Simulation of arrhythmogenic effect of rogue RyRs in failing heart by using a coupled model," Comput. Math. Methods Med., vol. 9, p. e106602, 2012.
22. J. F. Gomez et al., "Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1d simulation study," PLoS ONE, vol. 9, no. 9, p. e106602, Sep. 2014.
23. J. D. Moreno et al., "Ranolazine for congenital and acquired late INalinked arrhythmias: In silico pharmacological screening," Circulation Res., vol. 113, no. 7, pp. e50-e61, 2013.
24. R. Huang et al., "Cellular level electromechanical modeling and simulation of heart failure," in Proc. 27th Annu. Int. Conf. Eng. Med. Biol. Soc., Jan. 2005, pp. 7301-7304.
25. M. M. Elshrif et al., "Electrophysiological properties under heart failure conditions in a human ventricular cell: A modeling study," in Proc. 36th Annu. Int. Conf. Eng. Med. Biol. Soc., Aug. 2014, pp. 4324-4329.
26. E. Soltysinska et al., " Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts," Pflugers Arch., vol. 459, no. 1, pp. 11-23, 2009.
27. J. Prestle et al., "Heterogeneous transmural gene expression of calciumhandling proteins and natriuretic peptides in the failing human heart," Cardiovasc. Res., vol. 43, no. 2, pp. 323-331, 1999.
28. F. G. Akar and D. S. Rosenbaum, "Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure," Circulation Res., vol. 93, no. 7, pp. 638-645, 2003.
29. C. R. Valdivia et al., "Increased late sodium current in myocytes from a canine heart failure model and from failing human heart," J. Molecular Cellular Cardiol., vol. 38, no. 3, pp. 475-483, 2005.
30. L. L. Shang et al., "Human heart failure is associated with abnormal c-terminal splicing variants in the cardiac sodium channel," Circulation Res., vol. 101, no. 11, pp. 1146-1154, 2007.
31. G. Gao et al., "Role of rbm25/luc7l3 in abnormal cardiac sodium channel splicing regulation in human heart failure," Circulation, vol. 124, no. 10, pp. 1124-1131, 2011.
32. A. I. Undrovinas et al., "Gating of the late Na+ channel in normal and failing human myocardium," J. Molecular Cellular Cardiol., vol. 34, no. 11, pp. 1477-1489, 2002.
33. V. A. Maltsev and A. I. Undrovinas, "A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes," Cardiovasc. Res., vol. 69, no. 1, pp. 116-127, 2006.
34. V. A. Maltsev et al., "Chronic heart failure slows late sodium current in human and canine ventricular myocytes: Implications for repolarization variability," Eur. J. Heart Failure, vol. 9, no. 3, pp. 219-227, 2007.
35. R. P. Rasmussen et al., "Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium," Biochem. Pharmacol., vol. 39, no. 4, pp. 691-696, 1990.
36. D. J. Beuckelmann et al., "Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure," J. Molecular Cellular Cardiol., vol. 23, no. 8, pp. 929-937, 1991.
37. D. Beuckelmann and E. Erdmann, "Ca(2+)-currents and intracellular [Ca2+ ]i-transients in single ventricular myocytes isolated from terminally failing human myocardium," Basic Res. Cardiol., vol. 87, no. Suppl 1, pp. 235-243, 1992.
38. T. Mewes and U. Ravens, "L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium," J. Molecular Cellular Cardiol., vol. 26, no. 10, pp. 1307-1320, 1994.
39. G. F. Tomaselli et al., "Sudden cardiac death in heart failure. the role of abnormal repolarization." Circulation, vol. 90, no. 5, pp. 2534-2539, 1994.
40. H. Ouadid et al., "Calcium currents in diseased human cardiac cells," J. Cardiovasc. Pharmacol., vol. 25, no. 2, pp. 282-291, 1995.
41. F. Schröder et al., "Increased availability and open probability of single l-type calcium channels from failing compared with nonfailing human ventricle," Circulation, vol. 98, no. 10, pp. 969-976, 1998.
42. S. Kääb et al., "Molecular basis of transient outward potassium current downregulation in human heart failure: A decrease in Kv4.3 mRNA correlates with a reduction in current density," Circulation, vol. 98, no. 14, pp. 1383-1393, 1998.
43. R. Schwinger et al., "Regional expression and functional characterization of the l-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts," J. Molecular Cellular Cardiol., vol. 31, no. 1, pp. 283-296, 1999.
44. X. Chen et al., "L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices," Circulation Res., vol. 91, no. 6, pp. 517-524, 2002.
45. L. Gui-Rong et al., "Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles," Heart Rhythm, vol. 1, no. 4, pp. 460-468, 2004.
46. D. J. Beuckelmann et al., "Alterations of k+ currents in isolated human ventricular myocytes from patients with terminal heart failure," Circulation Res., vol. 73, no. 2, pp. 379-385, 1993.
47. M. Näbauer et al., "Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure," Circulation Res., vol. 73, no. 2, pp. 386-394, 1993.
48. E. Wettwer et al., "Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin." Circulation Res., vol. 75, no. 3, pp. 473-82, 1994.
49. M. Näbauer et al., "Regional differences in current density and ratedependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle," Circulation, vol. 93, no. 1, pp. 168-177, 1996.
50. K. M. Holzem and I. R. Efimov, "Arrhythmogenic remodelling of activation and repolarization in the failing human heart," Europace, vol. 14, no. suppl 5, pp. v50-v57, 2012.
51. T. Takahashi et al., "Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure," J. Clin. Investigation, vol. 90, no. 3, pp. 927-935, Sep. 1992.
52. S. Koumi et al., "Characterization of inwardly rectifying k+ channel in human cardiac myocytes:Alterations in channel behavior inmyocytes isolated from patients with idiopathic dilated cardiomyopathy," Circulation, vol. 92, no. 2, pp. 164-174, 1995.
53. M. J. Janse, "Electrophysiological changes in heart failure and their relationship to arrhythmogenesis," Cardiovasc. Res., vol. 61, no. 2, pp. 208-217, 2004.
54. F. G. Akar et al., "Molecular mechanisms underlying k+ current downregulation in canine tachycardia-induced heart failure," Am. J. Physiol., Heart Circulatory Physiol., vol. 288, no. 6, pp. H2887-H2896, 2005.
55. Y. Tsuji et al., "Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle," Cardiovasc. Res., vol. 48, no. 2, pp. 300-309, 2000.
56. J. Rose et al., "Molecular correlates of altered expression of potassium currents in failing rabbit myocardium," Am. J. Physiol., Heart Circulatory Physiol., vol. 288, no. 5, pp. H2077-H2087, 2005.
57. G.-R. Li et al., "Transmural action potential and ionic current remodeling in ventricles of failing canine hearts," Am. J. Physiol., Heart Circulatory Physiol., vol. 283, no. 3, pp. H1031-H1041, 2002.
58. R. Studer et al., "Gene expression of the cardiac Na+-Ca2+ exchanger in end-stage human heart failure," Circulation Res., vol. 75, no. 3, pp. 443-453, 1994.
59. M. Flesch et al., "Evidence for functional relevance of an enhanced expression of the Na+-Ca2+ exchanger in failing human myocardium," Circulation, vol. 94, no. 5, pp. 992-1002, 1996.
60. H. Reinecke et al., "Cardiac Na+/Ca2+ exchange activity in patients with end-stage heart failure," Cardiovasc. Res., vol. 31, no. 1, pp. 48-54, 1996.
61. G. Hasenfuss et al., "Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium," Circulation, vol. 99, no. 5, pp. 641-648, 1999.
62. K. Kjeldsen et al., "Na+,k+-atpase concentration in rodent and human heart and skeletal muscle: Apparent relation to muscle performance," Cardiovasc. Res., vol. 22, no. 2, pp. 95-100, 1988.
63. A. Nørgaard et al., "Relation of left ventricular function and Na+-k+ pump concentration in suspected idiopathic dilated cardiomyopathy," Am. J. Cardiol., vol. 61, no. 15, p. 1312-1315, 1988.
64. R. H. G. Schwinger et al., "Reduced sodium pump a1, a3, and ß1-isoform protein levels and Na+,k+-atpase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure," Circulation, vol. 99, no. 16, pp. 2105-2112, 1999.
65. R. H. Schwinger et al., "Effectiveness of cardiac glycosides in human myocardium with and without downregulated beta-adrenoceptors," J. Cardiovasc. Pharmacol., vol. 15, no. 5, p. 6927, 1990.
66. O. I. Shamraj et al., "Characterisation of na+-k+-atpase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts," Cardiovasc. Res., vol. 27, no. 12, pp. 2229-2237, 1993.
67. J. J. Mercadier et al., "Altered sarcoplasmic reticulum Ca2(+)-atpase gene expression in the human ventricle during end-stage heart failure." J. Clinical Investigation, vol. 85, no. 1, pp. 305-309, Jan. 1990.
68. G. Hasenfuss et al., " Calcium cycling proteins and force-frequency relationship in heart failure," Basic Res. Cardiol., vol. 91, no. 1, pp. 17-22, 1996.
69. M. Arai et al., "Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium." Circulation Res., vol. 72, no. 2, pp. 463-469, 1993.
70. K. Dipla et al., "The sarcoplasmic reticulum and the na+/ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes," Circulation Res., vol. 84, no. 4, pp. 435-444, 1999.
71. G. Hasenfuss and B. Pieske, "Calcium cycling in congestive heart failure," J. Molecular Cellular Cardiol., vol. 34, no. 8, pp. 951-969, 2002.
72. T. Yamamoto et al., "Abnormal Ca2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure," Cardiovasc. Res., vol. 44, no. 1, pp. 146-155, 1999.
73. M. T. Jiang et al., "Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure," Circulation Res., vol. 91, no. 11, pp. 1015-1022, 2002.
74. V. Piacentino et al., "Cellular basis of abnormal calcium transients of failing human ventricular myocytes," Circulation Res., vol. 92, no. 6, pp. 651-658, 2003.
75. Y. Sakakibara et al., "Sodium current in isolated human ventricular myocytes," Am. J. Physiol., Heart Circulatory Physiol., vol. 265, no. 4, pp. H1301-H1309, 1993.
76. V. A. Maltsev et al., "Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes," Circulation, vol. 98, no. 23, pp. 2545-2552, 1998.
77. S. Zicha et al., "Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts," J. Physiol., vol. 561, no. 3, pp. 735-748, 2004.
78. C. Zobel et al., "Molecular dissection of the inward rectifier potassium current (iK 1 ) in rabbit cardiomyocytes: Evidence for heteromeric coassembly of Kir2.1 and Kir2.2," J. Physiol., vol. 550, no. 2, pp. 365-372, 2003.
79. S. Kääb et al., "Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure," Circulation Res., vol. 78, no. 2, pp. 262-273, 1996.
80. E. Watanabe et al., "Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure," Circulation J., vol. 71, no. 4, pp. 471-478, 2007.
81. R. Studer et al., " Expression and function of the cardiac Na+/Ca2+ exchanger in postnatal development of the rat, in experimentaliduced cardiac hypertrophy and in the failing human heart," Basic Res. Cardiol., vol. 92, no. 1, pp. 53-58, 1997.
82. P. D. Allen et al., "Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium," Basic Res. Cardiol, vol. 87, no. Suppl 1, p. 8794, 1992.
83. E. M. Cherry and F. H. Fenton, "A tale of two dogs: analyzing two models of canine ventricular electrophysiology," Am. J. Physiol., Heart Circulatory Physiol., vol. 292, no. 1, pp. H43-H55, 2007.
84. E. Pueyo et al., "Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction," IEEE Trans. Biomed. Eng., vol. 51, no. 9, pp. 1511-1520, Sep. 2004.
85. C. P. Lau et al., "Hysteresis of the ventricular pacedQTinterval in response to abrupt changes in pacing rate," Cardiovasc. Res., vol. 22, no. 1, pp. 67-72, 1988.
86. M. R. Franz et al., "Cycle length dependence of human action potential duration in vivo. effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies," J. Clinical Investigation, vol. 82, no. 3, pp. 972-979, 1988.
87. M. M. Elshrif and E. M. Cherry, "A quantitative comparison of the behavior of human ventricular cardiac electrophysiology models in tissue," PLoS ONE, vol. 9, no. 1, p. e84401, Jan. 2014.
88. S. Rush and H. Larsen, "A practical algorithm for solving dynamic membrane equations," IEEE Trans. Biomed. Eng., vol. BME-25, no. 4, pp. 389-392, Jul. 1978.
89. A. L. Hodgkin and A. F. Huxley, " A quantitative description ofmembrane current and its application to conduction and excitation in nerve," Bull. Math. Biol., vol. 52, no. 1-2, pp. 25-71, 1990.
90. A. Gorgels et al., "Ventricular arrhythmias in heart failure," Am. J. Cardiol., vol. 70, no. 10, p. 37C43C, 1992.
91. D. J. Beuckelmann et al., "Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure." Circulation, vol. 85, no. 3, pp. 1046-1055, 1992.
92. Y. A. Kuryshev et al., "Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes: Implications for the arrhythmogenesis of human siderotic heart disease," Circulation, vol. 100, no. 6, pp. 675-683, 1999.
93. C. R. Weber et al., "Dynamic regulation of sodium/calcium exchange function in human heart failure," Circulation, vol. 108, no. 18, pp. 2224-2229, 2003.
94. J. K. Gwathmey et al., "Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure." Circulation Res., vol. 61, no. 1, pp. 70-76, 1987.
95. D. M. Bers, Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, The Netherlands: Kluwer, 2001.
96. L. D. Wilson et al., "Heart failure enhances susceptibility to arrhythmogenic cardiac alternans," Heart Rhythm, vol. 6, no. 2, pp. 251-259, 2009.